Skip to main content
Equibles
AMS logo

AMS · American Shared Hospital Services · Metrics

Track AMS — free

Use AMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.28 +0.01 (+0.79%) Q2 2026 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, these conditions raise substantial doubt about the Company's ability to continue as a going concern. ... management has determined that the Company's liquidity condition raises substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$8.45M
Shares
6.65M
Volume · Oct 28 10.57K Avg daily vol (3M) 12.61K

AMS metrics

95 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.27
Market cap
$8.45M

Price action

20 metrics
Price change (1W)
+1.6%
Price change (30D)
-11.2%
Price change (3M)
-19.6%
Price change (6M)
-4.5%
Price change (YTD)
-39.8%
Price change (1Y)
-42.3%
Trailing year
Price change (5Y)
-55.3%
52-week high
$2.29
52-week low
$1.25
Change from 52-week high
-44.5%
Change from 52-week low
+1.6%
Annualized volatility
59.4%
Annualized volatility (3M)
35.5%
Beta
-0.1
RSI (14D)
37.6
Price vs SMA 50
-9.2%
Price vs SMA 200
-21.9%
Avg volume (3M)
12,613
Relative volume
0.8
Average dollar volume
$18,375

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
6.65M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.6×
reciprocal yield 167.6%
EV / EBITDA
10.0×
reciprocal yield 10.0%
EV / EBIT
—
P / sales
0.3×
reciprocal yield 360.1%
P / book
0.4
reciprocal yield 273.6%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
1.6
reciprocal yield 63.4%
Earnings yield
-17.6%

Historical valuation

8 metrics
P / E historical average (3Y)
18.2×
reciprocal yield 5.5%
P / E historical average (5Y)
23.6×
reciprocal yield 4.2%
EV / revenue historical average (3Y)
0.8×
reciprocal yield 118.6%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 107.1%
EV / EBIT historical average (3Y)
45.9×
reciprocal yield 2.2%
EV / EBIT historical average (5Y)
54.9×
reciprocal yield 1.8%
EV / EBITDA historical average (3Y)
9.2×
reciprocal yield 10.9%
EV / EBITDA historical average (5Y)
8.6×
reciprocal yield 11.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
17.1%
Operating margin
-11.8%
Trailing 12 months
Net margin
-4.9%
Gross profit (TTM)
$5.21M
Operating profit (TTM)
−$3.58M
Net income (TTM)
−$1.49M
Trailing 12 months
Diluted EPS (TTM)
$-0.25
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$4.52
Gross profit per diluted share (TTM)
$0.77
Operating profit per diluted share (TTM)
$-0.53
EBITDA per diluted share (TTM)
$0.27
Net income per diluted share (TTM)
$-0.22
Operating cash flow per diluted share (TTM)
$0.79
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.06
Book value per share
$3.92

Growth

11 metrics
Revenue growth YoY
+19.2%
Year over year
Net income growth YoY
-171.0%
Revenue (TTM)
$30.41M
Trailing 12 months
EPS growth YoY
-169.7%
Shares change YoY
+4.4%
Year over year · more shares
Revenue CAGR (3Y)
+12.5%
Revenue CAGR (5Y)
+9.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-6.4%
Return on assets
-2.8%
Debt / equity
0.7
Current ratio
0.8
EBITDA (TTM)
$1.82M
Free cash flow (TTM)
—
Quick ratio
0.8
Interest coverage
-2.7
Net debt / EBITDA
5.3
Return on invested capital
—
Trailing 12 months
Net cash
−$9.71M
Latest balance sheet
Cash & equivalents
$6.51M
Total assets
$52.49M
Total debt
$16.22M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.35M
Capital expenditures (TTM)
$1.82M
R&D (TTM)
—
SG&A (TTM)
$7.48M
Stock compensation (TTM)
$404,000
R&D / revenue
—
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
20
13F filer change QoQ
-1
Institutional ownership
7.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
3.1%
Private-fund adviser ownership
2.9%
Active holders' share change QoQ
-50.0%
Holder tenure
13.8
Price vs estimated holder cost
-31.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.2%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
22 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 744825 CUSIP 029595105 13F (30d) 1 filings 1 filers Visit website Investor relations